Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: Same results, more savings · pen still. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The headline frames the deal as no trade-off, and the checklist stacks three separate reasons to buy, each with its own emoji (a stopwatch, a calendar, cash) so you can scan it in a second. Each claim gets its own footnote, so the fine print is matched to the line it qualifies. The hand holding the pen, with nails painted the same yellow as the headline accent, makes the product feel held and real rather than floating, and ties the image to the color system.
Same results is the headline, but the ad doesn't say same as what until you read the footnote comparing it with the autoinjector pen. A viewer new to GLP-1s won't know there's an older version to compare against. If you make one like this, name the comparison in the headline itself (same medication as the weekly pen, half the price), so the promise works for someone seeing it cold.
It frames the offer as no trade-off between results and price.
It stacks three distinct reasons to buy in a format you can scan in a second.
The held product feels real and in reach, and the nail color ties into the headline accent.
Half the price, framed against the manufacturer list price of the Zepbound autoinjector pen when paying cash.
The ad lands on Ro's quiz entry, which opens on a choice between GLP-1 pill, GLP-1 shot, both, or a provider recommendation. A viewer interested in this pen can choose the shot and move on, so the path is short. None of the three checklist claims appear on the page, though, and the price message is reduced to a general line in the top bar. Repeating the same three-row checklist beside the shot option would give this visitor the reasons they clicked for.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.